Increased Ornithine-Derived Polyamines Cause Airway Hyperresponsiveness in a Mouse Model of Asthma
- 1 June 2013
- journal article
- Published by Oxford University Press (OUP) in American Journal of Respiratory Cell and Molecular Biology
- Vol. 48 (6) , 694-702
Abstract
Up-regulation of arginase contributes to airways hyperresponsiveness (AHR) in asthma by reducing l-arginine bioavailability for the nitric oxide (NO) synthase isozymes. The product of arginase activity, l-ornithine, can be metabolized into polyamines by ornithine decarboxylase. We tested the hypothesis that increases in l-ornithine–derived polyamines contribute to AHR in mouse models of allergic airways inflammation. After measuring significantly increased polyamine levels in sputum samples from human subjects with asthma after allergen challenge, we used acute and subacute ovalbumin sensitization and challenge mouse models of allergic airways inflammation and naive mice to investigate the relationship of AHR to methacholine and polyamines in the lung. We found that spermine levels were elevated significantly in lungs from the acute model, which exhibits robust AHR, but not in the subacute murine model of asthma, which does not develop AHR. Intratracheal administration of spermine significantly augmented airways responsiveness to methacholine in both naive mice and mice with subacute airways inflammation, and reduced nitrite/nitrate levels in lung homogenates, suggesting that the AHR developed as a consequence of inhibition of constitutive NO production in the airways. Chronic inhibition of polyamine synthesis using an ornithine decarboxylase inhibitor significantly reduced polyamine levels, restored nitrite/nitrate levels to normal, and abrogated the AHR to methacholine in the acute model of allergic airways inflammation. We demonstrate that spermine increases airways responsiveness to methacholine, likely through inhibition of constitutive NO synthesis. Thus, inhibition of polyamine production may represent a new therapeutic target to treat airway obstruction in allergic asthma.Keywords
This publication has 58 references indexed in Scilit:
- Augmentation of arginase 1 expression by exposure to air pollution exacerbates the airways hyperresponsiveness in murine models of asthmaRespiratory Research, 2011
- Polyamines Impair Immunity to Helicobacter pylori by Inhibiting L-Arginine Uptake Required for Nitric Oxide ProductionGastroenterology, 2010
- 2-Aminoimidazole Amino Acids as Inhibitors of the Binuclear Manganese Metalloenzyme Human Arginase IJournal of Medicinal Chemistry, 2010
- Arginase inhibition in airways from normal and nitric oxide synthase 2-knockout mice exposed to ovalbuminToxicology and Applied Pharmacology, 2010
- Arginase: a key enzyme in the pathophysiology of allergic asthma opening novel therapeutic perspectivesBritish Journal of Pharmacology, 2009
- Alterations of the Arginine Metabolome in AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Arginase Inhibition Protects against Allergen-induced Airway Obstruction, Hyperresponsiveness, and InflammationAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Arginases I and II in lungs of ovalbumin-sensitized mice exposed to ovalbumin: Sources and consequencesToxicology and Applied Pharmacology, 2008
- Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesisJournal of Clinical Investigation, 2003
- Increased arginase activity underlies allergen‐induced deficiency of cNOS‐derived nitric oxide and airway hyperresponsivenessBritish Journal of Pharmacology, 2002